Hello. Sign In
Standards Store

Fetal Cardiology: Embryology, Genetics, Physiology, Echocardiographic Evaluation, Diagnosis and Perinatal Management of Cardiac Diseases

2008 Edition, December 22, 2008

Complete Document

Detail Summary

Active, Most Current

Additional Comments:
ISBN: 978-1-4398-0798-9
Price (USD)
Add to Cart

Product Details:

  • Revision: 2008 Edition, December 22, 2008
  • Published Date: December 22, 2008
  • Status: Active, Most Current
  • Document Language: English
  • Published By: CRC Press (CRC)
  • Page Count: 802
  • ANSI Approved: No
  • DoD Adopted: No

Description / Abstract:


This second edition of Fetal Cardiology: Embryology, Genetics, Physiology, Echocardiographic Evaluation, Diagnosis and Perinatal Management of Cardiac Diseases is, like the first, the product of the combined efforts of many professionals: obstetricians, pediatric cardiologists, sonographers, molecular biologists, and medical physicists. The field of fetal ultrasonographic and echocardiographic imaging and fetal cardiac therapies and interventions is rapidly changing and developing, and is therefore in constant need of updating. Over the very few years between the first and second editions, considerable strides have been made in all aspects of fetal cardiology. Chapters have been added on many aspects of fetal cardiology, including the cardiac impact of the twinto- twin transfusion syndrome, cerebral outcomes in congenital heart disease (CHD), and congestive heart failure, and virtually all have been updated. In two areas advances have been particularly noteworthy: the identification of additional genes implicated in CHD, and the advances in three- and four-dimensional (3D/4D) ultrasound (US) capabilities in fetal cardiac imaging.

The 3D/4D revolution has opened exciting avenues for clinical applications and research endeavors in fetal cardiology, and is perhaps the main impetus for the second edition. Motion gating technology has overcome much inherent difficulty in 3D fetal cardiac scanning, and now allows near real-time 3D/4D heart examination. The burgeoning 3D/4D US–based literature shows that these modalities contribute to our understanding of the normal and anomalous fetal heart, to interdisciplinary management team consultation, to parental counseling, and to professional training. 3D/4D ultrasound applications have been shown to facilitate screening programs, and through offline networking capabilities to improve healthcare delivery systems, to extend the benefits of advanced prenatal cardiac screening to patients far from well-equipped centers. 3D/4D US has added virtual planes to fetal cardiac scanning: views of the fetal heart not generally accessible with a standard 2D approach.

The broad classification congenital heart disease includes the most common congenital malformations, commonly estimated to be 8:1000 live births. As many more are thought to die in utero or abort spontaneously. This is an important aspect of fully integrated comprehensive fetal echocardiography in every targeted organ scan. Many books have been devoted to detection of fetal anomalies, and many to Doppler techniques. Most of these volumes devote only one chapter to fetal cardiac malformations. This is a comprehensive guide intended for anyone interested in fetal organ scanning. Anyone performing targeted organ scans or having an interest in the fetal heart, we believe, will find it useful.

It is our hope that this volume will bridge among the specialties: obstetricians, pediatric cardiologists, and general cardiologists. To this end we have included chapters on treatment options and pharmacological or surgical interventions available to affected fetuses, as well as all life stages of heart disease, from embryology and the genes involved in cardiac development, to the reproductive health of women with CHD, and counseling of families affected with CHD. We also discuss the often-ignored placenta, an indivisible part of the cardiovascular system, which receives 50% of fetal blood volume. The subject of maternal status and how the mother's treatments will affect the fetal heart is included, as well as future fetal treatments only now being developed.